XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

160 hedge funds and large institutions have $1.03B invested in Intersect ENT, Inc in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.19M
Puts
$3.41M
Net Calls
Net Calls Change

Top Buyers

1 +$30.1M
2 +$17.3M
3 +$14.9M
4
BlackRock
BlackRock
New York
+$13.9M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$13M

Top Sellers

1 -$20.1M
2 -$19.6M
3 -$13.6M
4
Millennium Management
Millennium Management
New York
-$8.89M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$8.45M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$3.31M
52
$3.3M
53
$3.18M
54
$3.12M
55
$3.1M
56
$3.09M
57
$3.07M
58
$2.88M
59
$2.71M
60
$2.54M
61
$2.45M
62
$2.33M
63
$2.12M
64
$2.12M
65
$2.06M
66
$1.92M
67
$1.84M
68
$1.83M
69
$1.82M
70
$1.74M
71
$1.73M
72
$1.7M
73
$1.7M
74
$1.69M
75
$1.64M